Vitamin K2 Market by Application (Health Supplements, Functional Food & Beverages, Pharmaceutical), Product Type (MK-7, MK-4), Application Form (Capsules & Tablets, Powder & Crystalline, Liquids), Source, Function, and Region - Global Forecast to 2031

icon1
USD 339.9 MN
MARKET SIZE, 2031
icon2
CAGR 13.7%
(2026-2031)
icon3
300
REPORT PAGES
icon4
150
MARKET TABLES

OVERVIEW

vitamin-k2-market Overview

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

The Vitamin K2 market is projected to reach USD 339.9 million by 2031 from USD 179.0 million in 2026, at a CAGR of 13.7% from 2026 to 2031. The growth of this market is fueled by increasing consumer awareness of bone and cardiovascular health, rising demand for preventive healthcare, and growing adoption of dietary supplements, functional foods and beverages, and pharmaceutical products containing Vitamin K2.

Market Size and Forecast:

  • Market Size Value in 2025: USD 158.0 Million
  • Market Size Value in 2026: USD 179 Million
  • Revenue Forecast in 2031: USD 339.9 Million
  • Growth Rate: CAGR of 13.7% from 2026 to 2031
  • Data available from 2022 to 2031
  • Base year: 2025
  • Forecast period: 2026–2031
  • The Asia Pacific region is projected to register the highest CAGR of 14.2% during the forecast period.
  • The health supplements segment is estimated to account for the largest market share of 80.9% in 2026.

Key Market Trends and Insights

  • By Product Type: MK-7 and MK-4 vitamin K2 products are witnessing strong demand due to their superior bioavailability and expanding use in dietary supplements, functional foods, and nutraceutical formulations. 
  • Growth Drivers: Increasing awareness of vitamin K2's role in calcium metabolism, bone health, cardiovascular health, and healthy aging, along with rising demand for preventive healthcare solutions, is fueling market growth. 
  • Growing Trends: Rising consumption of vitamin K2-enriched dietary supplements, functional foods, and vitamin D3 + K2 combination products, coupled with growing interest in personalized nutrition, clean-label ingredients, and plant-based wellness products, is accelerating market expansion. 
  • Growth Opportunities: Expansion of the nutraceutical and dietary supplement industries, increasing awareness of bone and heart health, growing aging populations, higher demand for functional foods and beverages, and rising penetration in emerging markets are creating significant growth opportunities for the vitamin K2 market. 

KEY TAKEAWAYS

  • By Region
    The Asia Pacific region is projected to register the highest CAGR of 14.2% during the forecast period.
  • By Application
    The health supplements segment is estimated to account for the largest market share of 80.9% in 2026.
  • By Source
    The natural origin segment is projected to register the highest growth in the vitamin K2 market from 2026 to 2031 with a CAGR of 13.7%.
  • By Application Form
    The capsules and tablets segment is estimated to account for the largest market share of 64.4% in 2026.
  • By Product Type
    MK-7 is estimated to account for the largest share of the vitamin K2 market in 2026.
  • COMPETITIVE LANDSCAPE - KEY PLAYERS
    Gnosis by Lesaffre (France), Balchem Corporation (US), J-OIL MILLS, INC. (Japan), Novonesis A/S (Denmark), and Guangdong Sungen Bioscience Co., Ltd. (China) are some of the star players in the vitamin K2 market, given their global presence and strong product footprint.
  • COMPETITIVE LANDSCAPE - DISTRIBUTORS
    MAGNESIA GmbH (Germany) and Falcon Trading International (US) are some of the progrssive distributors in the vitamin K2 market.

The Vitamin K2 market is expected to grow at a stable rate due to increasing awareness of the health benefits associated with Vitamin K2, rising consumer spending on preventive healthcare and nutritional supplements, and growing demand for functional ingredients. Demand is further supported by the increasing aging population, expanding applications in bone and cardiovascular health, and the growth of functional foods and dietary supplements that improve product accessibility. Manufacturers are also introducing high-purity, fermentation-derived, and scientifically validated Vitamin K2 ingredients to cater to evolving consumer preferences, contributing to sustained market growth.

TRENDS & DISRUPTIONS IMPACTING CUSTOMERS' CUSTOMERS

Trends in the Vitamin K2 market are increasingly driven by growing consumer awareness of preventive healthcare and rising demand for scientifically supported nutritional ingredients. Manufacturers are increasingly developing advanced Vitamin K2 formulations across MK-4 and MK-7 product types to improve purity, bioavailability, stability, and application versatility. The market is also witnessing rising demand for naturally fermented Vitamin K2, personalized nutrition solutions, and functional ingredients designed to support bone health, cardiovascular health, blood clotting, and other targeted health applications.

vitamin-k2-market Disruptions

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

MARKET DYNAMICS

Drivers
Impact
Level
  • Rising health consciousness among consumers
  • Growing research and development activities
RESTRAINTS
Impact
Level
  • Inconsistency in regulatory norms
  • Price volatility of raw materials
OPPORTUNITIES
Impact
Level
  • Growing demand for natural and plant-based ingredients
  • Rising need for personalized nutrition and customized products
CHALLENGES
Impact
Level
  • Lack of consumer awareness regarding specific health benefits
  • High research and development costs

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

Driver: Rising health consciousness among consumers

Increasing consumer awareness regarding bone health, cardiovascular wellness, and preventive healthcare is driving demand for Vitamin K2 globally. Consumers are increasingly seeking scientifically validated ingredients that support calcium metabolism and healthy aging, resulting in higher adoption of Vitamin K2 across dietary supplements, functional foods and beverages, and pharmaceutical products. Growing interest in personalized nutrition, preventive healthcare, and functional ingredients further supports market expansion.

Restraint: Inconsistency in regulatory norms

Differences in regulatory approvals, health claim requirements, labeling standards, and permitted dosage levels across countries create challenges for Vitamin K2 manufacturers. Varying regulations governing MK-4 and MK-7 ingredients increase product registration complexity, prolong market entry timelines, and raise compliance costs, particularly for companies expanding into multiple regional markets.

Opportunity: Growing demand for natural and plant-based ingredients

Consumers are increasingly preferring naturally derived, clean-label, and sustainably produced nutritional ingredients, creating significant opportunities for fermentation-derived Vitamin K2. Rising demand for plant-based and vegetarian supplements, coupled with increasing preference for naturally fermented ingredients over synthetic alternatives, is encouraging manufacturers to invest in advanced fermentation technologies and innovative product development.

Challenge: Lack of consumer awareness regarding specific health benefits

Although awareness of dietary supplements continues to grow, many consumers remain unfamiliar with the distinct physiological benefits of Vitamin K2 and its role in calcium utilization, bone mineralization, and cardiovascular health. Limited public awareness, confusion between Vitamin K1 and Vitamin K2, and insufficient clinical understanding in emerging markets continue to restrict broader product adoption and market penetration.

VITAMIN K2 MARKET TRENDS, GROWTH, AND FORECAST [LATEST]: COMMERCIAL USE CASES ACROSS INDUSTRIES

COMPANY USE CASE DESCRIPTION BENEFITS
Gnosis by Lesaffre developed the MenaQ7 natural Vitamin K2 ingredient through proprietary fermentation technology and continuously expanded its clinical research portfolio to validate its benefits for bone and cardiovascular health. The company also introduced specialized formulations such as MenaQ7 Matrix to improve formulation flexibility and ingredient stability. Strengthened scientific credibility, expanded adoption across dietary supplements and functional foods, improved formulation versatility for manufacturers, and reinforced the company's leadership in the premium Vitamin K2 market
Balchem incorporated the K2VITAL Vitamin K2 ingredient into its Human Nutrition & Health portfolio, enabling the company to offer integrated nutritional ingredient solutions for bone, cardiovascular, and healthy aging applications to dietary supplement manufacturers worldwide. Strengthened portfolio differentiation, improved customer access to complementary nutritional ingredients, increased global commercialization opportunities, and enhanced formulation flexibility
J-OIL MILLS commercialized its Menatto MK-7 ingredient produced through Bacillus subtilis natto fermentation and partnered with international distribution companies to expand its presence in North America and other global nutraceutical markets. Increased international market penetration, improved availability of naturally fermented Vitamin K2 ingredients, strengthened customer access, and supported growing demand for clean-label and clinically supported nutraceutical products

Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.

MARKET ECOSYSTEM

The Vitamin K2 market comprises a diverse ecosystem of raw material suppliers, Vitamin K2 manufacturers, ingredient formulators, dietary supplement manufacturers, functional food and beverage companies, pharmaceutical manufacturers, distributors, and retailers. The market is witnessing steady growth, driven by increasing consumer awareness of preventive healthcare, rising demand for bone and cardiovascular health solutions, expanding adoption of dietary supplements, and growing interest in functional nutrition. Leading nutraceutical ingredient manufacturers, biotechnology companies, and fermentation technology providers play a critical role in the market by developing high-purity Vitamin K2 ingredients across MK-4 and MK-7 product types. Market participants are increasingly focusing on innovation through advanced production technologies, including natural fermentation, chemical synthesis, biotechnological fermentation, and emerging manufacturing processes to improve ingredient purity, stability, and bioavailability. Additionally, growing demand for clean-label ingredients, naturally derived formulations, scientifically validated health benefits, and personalized nutrition is encouraging manufacturers to expand their product portfolios and strengthen their presence across dietary supplement, functional food and beverage, and pharmaceutical industries.

vitamin-k2-market Ecosystem

Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.

MARKET SEGMENTS

vitamin-k2-market Segments

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

By Source

Natural-origin Vitamin K2 is expected to witness the highest growth owing to increasing consumer preference for clean-label, naturally fermented, and scientifically validated ingredients. Growing demand for vegetarian and non-GMO formulations, coupled with rising awareness of the superior bioavailability and longer half-life of naturally fermented MK-7, continues to accelerate adoption across dietary supplements and functional food applications.

By Application Form

Capsules and tablets account for the largest share of the Vitamin K2 market due to their convenience, accurate dosage, extended shelf life, and widespread consumer acceptance. Their ease of manufacturing, compatibility with combination formulations containing Vitamin D3 and calcium, and broad availability through pharmacies and retail channels continue to strengthen segmental growth.

By Product Type

MK-7 holds the leading share of the Vitamin K2 market owing to its superior bioavailability, longer biological half-life, and stronger scientific evidence supporting bone and cardiovascular health benefits. Increasing demand for naturally fermented MK-7 ingredients, expanding clinical research, and widespread use in premium dietary supplements continue to reinforce the segment's market leadership.

By Application

Health supplements account for the largest share of the Vitamin K2 market due to increasing consumer preference for preventive healthcare and nutritional supplementation. Growing awareness of bone and cardiovascular health, rising adoption of daily wellness supplements, and increasing demand for scientifically supported ingredients are driving the widespread incorporation of Vitamin K2 into capsules, tablets, powders, and liquid supplement formulations.

REGION

Asia Pacific is projected to grow at the highest CAGR

The Asia Pacific region is emerging as the fastest-growing market for Vitamin K2, driven by a combination of demographic, economic, and lifestyle factors. One of the primary drivers of this growth is the region's rapidly aging population. Countries such as Japan, China, and South Korea are experiencing significant increases in their elderly population, who are more prone to bone-related ailments like osteoporosis and cardiovascular issues. This demographic shift is creating a substantial demand for nutritional supplements that support bone health and prevent arterial calcification, making Vitamin K2 a sought-after nutrient.

vitamin-k2-market Region

VITAMIN K2 MARKET TRENDS, GROWTH, AND FORECAST [LATEST]: COMPANY EVALUATION MATRIX

In the Vitamin K2 market matrix, Balchem Corporation is identified as a star player, supported by its strong global presence, broad Vitamin K2 product portfolio, extensive distribution network, and continuous investments in product innovation and scientific research. Meanwhile, Shandong Richen Nutritional Technology Co., Ltd., Menadiona S.L., and GF Fermentech Co., Ltd. are emerging leaders, strengthening their market position through specialized Vitamin K2 ingredients, advanced production technologies, science-backed product development, and expansion across dietary supplements, functional foods and beverages, and pharmaceutical applications.

vitamin-k2-market Evaluation Metrics

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

KEY MARKET PLAYERS

MARKET SCOPE

REPORT METRIC DETAILS
Market Size in 2025 (Value) USD 158.0 Million
Market Forecast in 2031 (Value) USD 339.9 Million
Growth Rate CAGR of 13.7% from 2026 to 2031
Years Considered 2022–2031
Base Year 2025
Forecast Period 2026–2031
Units Considered Value (USD Million), Volume (KT)
Report Coverage Revenue Forecast, Company Ranking, Competitive Landscape, Growth Factors, and Trends
Segments Covered
  • Product Type
  • MK-4
  • MK-7
  • Application
  • Pharmaceuticals
  • Functional Foods and Beverages
  • Health Supplements
  • Application Form
  • Capsules and Tablets
  • Powder and Crystalline
  • Liquids
  • Source
  • Natural Origin
  • Synthetic Origin
  • Production Technology
  • Natural Fermentation
  • Chemical Synthesis
  • Biotechnological Fermentation
  • Other Production Technologies
  • Function
  • Bone and Cardiovascular Health
  • Blood Health and Clotting
  • Anti-inflammatory and Immunity
  • Other Functions
Regions Covered North America, Asia Pacific, Europe, and Rest of the World (RoW)

WHAT IS IN IT FOR YOU: VITAMIN K2 MARKET TRENDS, GROWTH, AND FORECAST [LATEST] REPORT CONTENT GUIDE

vitamin-k2-market Content Guide

DELIVERED CUSTOMIZATIONS

We have successfully delivered the following deep-dive customizations:

CLIENT REQUEST CUSTOMIZATION DELIVERED VALUE ADDS
Vitamin K2 Ingredient Manufacturers
  • Detailed analysis of Vitamin K2 product types, competitive landscape, and company benchmarking (financials, product portfolio)
  • Customer landscape mapping by application
  • Assessment of market share and pricing analysis
  • Identified & profiled 15+ leading Vitamin K2 manufacturers
  • Tracked adoption trends across high-growth countries (China, Japan, US, Germany)
  • Highlighted emerging application opportunities driven by preventive healthcare and functional nutrition
Vitamin K2 Market Assessment
  • Segmentation of Vitamin K2 demand across MK-4 and MK-7, functions, application forms, sources, applications, and production technologies
  • Benchmarking adoption across pharmaceuticals, health supplements, and functional foods & beverages
  • Evaluation of regulatory landscape and production technologies
  • Market share analysis across product types and application segments
  • Identified growth opportunities in fermentation-derived Vitamin K2 and premium nutraceutical ingredients
  • Comparative assessment of regional regulatory frameworks and commercialization trends

RECENT DEVELOPMENTS

  • March 2024 : Gnosis by Lesaffre partnered with SunWay Biotech to launch MenaQ7 Metabolic, a new vitamin K2-based solution combining its clinically validated MenaQ7 MK-7 with SunWay's Ankascin 568-R red yeast rice extract. Introduced at Natural Products Expo West 2024, the formulation is designed to support cardiometabolic and cardiovascular health by promoting healthy cholesterol levels, arterial function, blood glucose management, and metabolic wellness, while addressing growing consumer demand for natural, science-backed health solutions
  • August 2023 : Richen Nutritional Technology Co., Ltd. introduced a new addition to its RiviK2 series Vitamin K2 (fermented) micro-encapsulated powder. This innovative product is designed to enhance bone health by offering improved application performance and stability.
  • April 2023 : GF Fermentech, a subsidiary of Genofocus, introduced organic nano-encapsulated vitamin K2 MK-7 products, expanding its MediQ7 range of vitamin K2 ingredients. Sourced from Bacillus subtilis natto derived from Cheonggukjang, a Korean traditional fermented food, the vitamin K2 ingredients focus on supporting heart, bone, kidney, and brain health. The new MediQ7 NanoEncap powder, derived from a concentration of 96% naturally fermented pure MK-7, boasts a 99.9% trans-type Menaquinone 7 aligned with USP standards. These ingredients are vegan, kosher, halal, GMP-, ISO 9001-, and ISO 22000-certified and are designed to offer enhanced efficacy, bioavailability, and stability.

 

Table of Contents

checkmarkExclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.

TITLE
PAGE NO
1
INTRODUCTION
 
 
 
 
 
27
2
EXECUTIVE SUMMARY
 
 
 
 
 
32
3
PREMIUM INSIGHTS
 
 
 
 
 
38
4
MARKET OVERVIEW
Capitalize on rising health consciousness and untapped opportunities in personalized nutrition to drive growth.
 
 
 
 
 
42
 
4.1
INTRODUCTION
 
 
 
 
 
 
4.2
MARKET DYNAMICS
 
 
 
 
 
 
 
4.2.1
DRIVERS
 
 
 
 
 
 
 
4.2.1.1
RISING HEALTH CONSCIOUSNESS AMONG CONSUMERS
 
 
 
 
 
 
4.2.1.2
INCREASING RESEARCH AND DEVELOPMENT ACTIVITIES
 
 
 
 
 
 
 
GROWING AGING POPULATION AND RISING PREVALENCE OF
 
 
 
 
 
4.2.2
RESTRAINTS
 
 
 
 
 
 
 
4.2.2.1
INCONSISTENCY IN REGULATORY NORMS
 
 
 
 
 
 
4.2.2.2
PRICE VOLATILITY OF RAW MATERIALS
 
 
 
 
 
4.2.3
OPPORTUNITIES
 
 
 
 
 
 
 
4.2.3.1
GROWING DEMAND FOR NATURAL AND PLANT-BASED INGREDIENTS
 
 
 
 
 
 
4.2.3.2
RISING NEED FOR PERSONALIZED NUTRITION AND CUSTOMIZED PRODUCTS
 
 
 
 
 
 
4.2.3.3
UNTAPPED APPLICATIONS
 
 
 
 
 
4.2.4
CHALLENGES
 
 
 
 
 
 
 
4.2.4.1
LACK OF CONSUMER AWARENESS REGARDING SPECIFIC HEALTH BENEFITS
 
 
 
 
 
 
4.2.4.2
HIGH RESEARCH AND DEVELOPMENT COSTS
 
 
 
 
4.3
UNMET NEEDS AND WHITE SPACES
 
 
 
 
 
 
 
4.3.1
UNMET NEEDS IN VITAMIN K2 MARKET
 
 
 
 
 
 
4.3.2
WHITE SPACE OPPORTUNITIES
 
 
 
 
 
4.4
INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES
 
 
 
 
 
 
 
4.4.1
INTERCONNECTED MARKETS
 
 
 
 
 
 
4.4.2
CROSS-SECTOR OPPORTUNITIES
 
 
 
 
 
4.5
STRATEGIC MOVES BY TIER-1/2/3 PLAYERS
 
 
 
 
 
 
 
4.5.1
KEY MOVES AND STRATEGIC FOCUS
 
 
 
 
5
INDUSTRY TRENDS
Navigate competitive dynamics and leverage macroeconomic shifts to capitalize on emerging industry opportunities.
 
 
 
 
 
55
 
5.1
PORTER’S FIVE FORCES ANALYSIS
 
 
 
 
 
 
 
5.1.1
INTENSITY OF COMPETITIVE RIVALRY
 
 
 
 
 
 
5.1.2
BARGAINING POWER OF SUPPLIERS
 
 
 
 
 
 
5.1.3
BARGAINING POWER OF BUYERS
 
 
 
 
 
 
5.1.4
THREAT OF SUBSTITUTES
 
 
 
 
 
 
5.1.5
THREAT OF NEW ENTRANTS
 
 
 
 
 
5.2
MACROECONOMICS OUTLOOK
 
 
 
 
 
 
 
5.2.1
INTRODUCTION
 
 
 
 
 
 
 
5.2.1.1
MACROECONOMIC INDICATORS
 
 
 
 
 
 
 
 
5.2.1.1.1
RISING WORLD GDP AND POPULATION
 
 
 
 
 
 
5.2.1.1.2
RISE IN HEALTH CONCERNS AND DISEASE INCIDENCES
 
 
5.3
VALUE CHAIN ANALYSIS
 
 
 
 
 
 
 
 
5.3.1
RESEARCH AND DEVELOPMENT
 
 
 
 
 
 
5.3.2
RAW MATERIAL SOURCING
 
 
 
 
 
 
5.3.3
PRODUCTION AND PROCESSING
 
 
 
 
 
 
5.3.4
QUALITY ASSURANCE
 
 
 
 
 
 
5.3.5
MARKETING, DISTRIBUTION, & SALES
 
 
 
 
 
 
5.3.6
END USERS
 
 
 
 
 
5.4
ECOSYSTEM ANALYSIS
 
 
 
 
 
 
 
 
5.4.1
DEMAND SIDE
 
 
 
 
 
 
5.4.2
SUPPLY SIDE
 
 
 
 
 
5.5
PRICING ANALYSIS
 
 
 
 
 
 
 
 
5.5.1
INTRODUCTION
 
 
 
 
 
 
 
AVERAGE SELLING PRICE (ASP) TREND, BY PRODUCT TYPE,
 
 
 
 
 
 
 
AVERAGE SELLING PRICE (ASP) TREND, BY REGION,
 
 
 
 
 
5.6
TRADE ANALYSIS
 
 
 
 
 
 
 
 
5.6.1
IMPORT ANALYSIS: VITAMINS AND THEIR DERIVATIVES
 
 
 
 
 
 
5.6.2
EXPORT ANALYSIS: VITAMINS AND THEIR DERIVATIVES
 
 
 
 
 
5.7
KEY CONFERENCES AND EVENTS, 2026–2027
 
 
 
 
 
 
5.8
TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
 
 
 
 
 
 
5.9
INVESTMENT AND FUNDING SCENARIO
 
 
 
 
 
 
5.10
CASE STUDY ANALYSIS
 
 
 
 
 
 
 
5.10.1
GNOSIS BY LESAFFRE – LAUNCH OF MENAQ7 OLIVE OIL
 
 
 
 
 
 
5.10.2
BALCHEM CORP.– ACQUISITION OF KAPPA BIOSCIENCE
 
 
 
 
 
5.11
IMPACT OF 2025 US TARIFF – VITAMIN K2 MARKET
 
 
 
 
 
 
 
 
5.11.1
INTRODUCTION
 
 
 
 
 
 
5.11.2
PRICE IMPACT ANALYSIS
 
 
 
 
 
 
5.11.3
IMPACT ON COUNTRIES/REGIONS
 
 
 
 
 
 
 
5.11.3.1
US
 
 
 
 
 
 
5.11.3.2
EUROPE
 
 
 
 
 
 
5.11.3.3
ASIA PACIFIC
 
 
 
 
 
5.11.4
IMPACT ON END-USE INDUSTRIES
 
 
 
 
 
TECHNOLOGY ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS,
 
 
 
 
 
 
 
6.1
TECHNOLOGY ANALYSIS
 
 
 
 
 
 
 
6.1.1
KEY TECHNOLOGIES
 
 
 
 
 
 
 
6.1.1.1
FERMENTATION TECHNOLOGY
 
 
 
 
 
 
6.1.1.2
BIOREACTOR PROCESS CONTROL TECHNOLOGY
 
 
 
 
 
6.1.2
COMPLEMENTARY ANALYSIS
 
 
 
 
 
 
 
6.1.2.1
ENCAPSULATION TECHNOLOGY
 
 
 
 
 
 
6.1.2.2
SPRAY DRYING TECHNOLOGY
 
 
 
 
 
6.1.3
ADJACENT TECHNOLOGIES
 
 
 
 
 
 
 
6.1.3.1
SYNTHETIC BIOLOGY
 
 
 
 
 
 
6.1.3.2
CONTINUOUS MANUFACTURING TECHNOLOGY
 
 
 
 
 
6.1.4
TECHNOLOGY/PRODUCT ROADMAP
 
 
 
 
 
 
 
6.1.4.1
SHORT-TERM | PROCESS OPTIMIZATION & HIGH-PURITY INGREDIENT EXPANSION
 
 
 
 
 
 
6.1.4.2
MID-TERM | PERSONALIZED NUTRITION & SUSTAINABLE BIOPROCESSING
 
 
 
 
 
 
6.1.4.3
LONG-TERM | SYNTHETIC BIOLOGY & NEXT-GENERATION PRECISION HEALTH
 
 
 
 
6.2
PATENT ANALYSIS
 
 
 
 
 
 
 
6.3
FUTURE APPLICATIONS
 
 
 
 
 
 
 
6.3.1
AI-DRIVEN PRECISION FERMENTATION: OPTIMIZING VITAMIN K2 PRODUCTION
 
 
 
 
 
 
 
SYNTHETIC BIOLOGY: ENGINEERING HIGH-PERFORMANCE
 
 
 
 
 
 
 
PRECISION NUTRITION & PERSONALIZED SUPPLEMENTATION:
 
 
 
 
 
 
 
ADVANCED DELIVERY SYSTEMS & SMART FORMULATIONS:
 
 
 
 
 
 
 
DIGITAL MANUFACTURING & SMART QUALITY CONTROL:
 
 
 
 
 
6.4
IMPACT OF GENERATIVE AI ON VITAMIN K2 MARKET
 
 
 
 
 
 
 
6.4.1
INTRODUCTION
 
 
 
 
 
 
6.4.2
CASE STUDIES OF AI IMPLEMENTATION IN VITAMIN K2 MARKET
 
 
 
 
 
 
 
INTERCONNECTED ADJACENT ECOSYSTEM AND
 
 
 
 
 
 
6.4.4
CLIENTS' READINESS TO ADOPT GENERATIVE AI IN VITAMIN K2 MARKET
 
 
 
 
 
6.5
SUCCESS STORIES AND REAL-WORLD APPLICATIONS
 
 
 
 
 
7
REGULATORY LANDSCAPE AND SUSTAINABILITY INITIATIVES
Navigate evolving regulations and sustainability mandates to future-proof your global operations.
 
 
 
 
 
84
 
7.1
REGIONAL REGULATIONS AND COMPLIANCE
 
 
 
 
 
 
 
7.1.1
REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
 
 
7.1.2
INDUSTRY STANDARDS
 
 
 
 
 
 
7.1.3
LABELING REQUIREMENTS AND CLAIMS
 
 
 
 
 
 
7.1.4
ANTICIPATED REGULATORY CHANGES IN NEXT 5-10 YEARS
 
 
 
 
 
 
 
7.1.4.1
ENHANCED INGREDIENT TRACEABILITY AND SUPPLY CHAIN TRANSPARENCY
 
 
 
 
 
 
7.1.4.2
GREATER HARMONIZATION OF GLOBAL REGULATORY STANDARDS
 
 
 
 
 
 
7.1.4.3
STRICTER SUSTAINABILITY AND RESPONSIBLE MANUFACTURING REQUIREMENTS
 
 
 
 
 
 
7.1.4.4
DIGITAL COMPLIANCE, SMART MANUFACTURING, AND QUALITY MANAGEMENT
 
 
 
 
 
 
 
EXPANDED REGULATION OF NOVEL PRODUCTION TECHNOLOGIES AND
 
 
 
 
 
 
7.1.4.6
STRENGTHENED LABELING AND CONSUMER TRANSPARENCY REQUIREMENTS
 
 
 
 
7.2
SUSTAINABILITY INITIATIVES
 
 
 
 
 
 
 
7.2.1
SUSTAINABLE SOURCING
 
 
 
 
 
 
7.2.2
CARBON FOOTPRINT REDUCTION INITIATIVES
 
 
 
 
 
 
7.2.3
CIRCULAR ECONOMY APPROACHES
 
 
 
 
 
7.3
IMPACT OF REGULATORY POLICIES ON SUSTAINABILITY INITIATIVES
 
 
 
 
 
 
7.4
CERTIFICATIONS, LABELING, ECO-STANDARDS
 
 
 
 
 
8
CUSTOMER LANDSCAPE AND BUYER BEHAVIOR
Unlock profitability by addressing unmet needs and stakeholder criteria in the Vitamin K2 market.
 
 
 
 
 
94
 
8.1
DECISION-MAKING PROCESS
 
 
 
 
 
 
8.2
KEY STAKEHOLDERS INVOLVED IN BUYING PROCESS AND THEIR EVALUATION CRITERIA
 
 
 
 
 
 
 
8.2.1
KEY STAKEHOLDERS IN BUYING PROCESS
 
 
 
 
 
 
8.2.2
BUYING CRITERIA
 
 
 
 
 
8.3
ADOPTION BARRIERS AND INTERNAL CHALLENGES
 
 
 
 
 
 
8.4
UNMET NEEDS OF VARIOUS APPLICATION INDUSTRIES ACROSS SUPPLY CHAIN
 
 
 
 
 
 
8.5
MARKET PROFITABILITY
 
 
 
 
 
 
8.6
REVENUE POTENTIAL
 
 
 
 
 
 
 
8.6.1
COST DYNAMICS
 
 
 
 
 
 
8.6.2
MARGIN OPPORTUNITIES, BY PRODUCT TYPE
 
 
 
 
9
VITAMIN K2 MARKET, BY FUNCTION
Market Size & Growth Rate Forecast Analysis
 
 
 
 
 
104
 
9.1
INTRODUCTION
 
 
 
 
 
 
9.2
BONE AND CARDIOVASCULAR HEALTH
 
 
 
 
 
 
 
9.2.1
RISING PREVALENCE OF OSTEOPOROSIS AND CARDIOVASCULAR DISORDERS TO DRIVE VITAMIN K2 ADOPTION IN BONE AND CARDIOVASCULAR HEALTH FORMULATIONS
 
 
 
 
 
9.3
BLOOD HEALTH AND CLOTTING
 
 
 
 
 
 
 
9.3.1
EFFICACY IN MANAGING CLOTTING DISORDERS TO BOOST MARKET GROWTH
 
 
 
 
 
9.4
ANTI-INFLAMMATORY AND IMMUNITY
 
 
 
 
 
 
 
9.4.1
THERAPEUTIC POTENTIAL AND IMMUNITY-SUPPORTING PROPERTIES TO SUPPORT MARKET GROWTH
 
 
 
 
 
9.5
OTHER FUNCTIONS
 
 
 
 
 
10
VITAMIN K2 MARKET, BY PRODUCTION TECHNOLOGY
| 1 Data Tables
 
 
 
 
 
108
 
10.1
INTRODUCTION
 
 
 
 
 
 
10.2
NATURAL FERMENTATION
 
 
 
 
 
 
 
10.2.1
PREFERRED PRODUCTION TECHNOLOGY FOR PREMIUM VITAMIN K2 (MK-7) DUE TO SUPERIOR BIOAVAILABILITY, NATURAL ORIGIN, AND STRONG CONSUMER ACCEPTANCE
 
 
 
 
 
10.3
CHEMICAL SYNTHESIS
 
 
 
 
 
 
 
10.3.1
COST-EFFECTIVE PRODUCTION AND HIGH MANUFACTURING SCALABILITY, PARTICULARLY FOR VITAMIN K2 (MK-4)
 
 
 
 
 
10.4
BIOTECHNOLOGICAL FERMENTATION
 
 
 
 
 
 
 
10.4.1
ENHANCES PRODUCTION EFFICIENCY THROUGH ADVANCED MICROBIAL ENGINEERING AND PRECISION BIOPROCESS TECHNOLOGIES
 
 
 
 
 
10.5
OTHER PRODUCTION TECHNOLOGIES
 
 
 
 
 
11
VITAMIN K2 MARKET, BY PRODUCT TYPE
Market Size & Growth Rate Forecast Analysis to 2031 in USD Million and Tons | 17 Data Tables
 
 
 
 
 
111
 
11.1
INTRODUCTION
 
 
 
 
 
 
11.2
MK7
 
 
 
 
 
 
 
11.2.1
HIGH BIOAVAILABILITY TO PROPEL MARKET GROWTH
 
 
 
 
 
11.3
MK4
 
 
 
 
 
 
 
 
POTENTIAL BENEFITS IN BONE AND CARDIOVASCULAR HEALTH TO
 
 
 
 
12
VITAMIN K2 MARKET, BY SOURCE
Market Size & Growth Rate Forecast Analysis to 2031 in USD Million | 6 Data Tables
 
 
 
 
 
119
 
12.1
INTRODUCTION
 
 
 
 
 
 
12.2
NATURAL
 
 
 
 
 
 
 
12.2.1
INCREASING CONSUMER PREFERENCE FOR NON-GMO SUPPLEMENTS TO BOOST MARKET GROWTH
 
 
 
 
 
12.3
SYNTHETIC
 
 
 
 
 
 
 
12.3.1
LOW PRODUCTION COST TO DRIVE MARKET
 
 
 
 
13
VITAMIN K2 MARKET, BY APPLICATION
Market Size & Growth Rate Forecast Analysis to 2031 in USD Million | 20 Data Tables
 
 
 
 
 
124
 
13.1
INTRODUCTION
 
 
 
 
 
 
13.2
HEALTH SUPPLEMENTS
 
 
 
 
 
 
 
13.2.1
GROWING ADOPTION OF PREVENTIVE NUTRITION AND CLINICALLY SUPPORTED DIETARY SUPPLEMENTS TO DRIVE SEGMENT
 
 
 
 
 
13.3
FUNCTIONAL FOOD & BEVERAGES
 
 
 
 
 
 
 
 
GROWING DEMAND FOR FORTIFIED FUNCTIONAL FOODS TO
 
 
 
 
 
13.4
PHARMACEUTICALS
 
 
 
 
 
 
 
 
RISING INVESTMENTS FOR DEVELOPING NEW FORMULATIONS TO
 
 
 
 
14
VITAMIN K2 MARKET, BY APPLICATION FORM
Market Size & Growth Rate Forecast Analysis to 2031 in USD Million | 8 Data Tables
 
 
 
 
 
134
 
14.1
INTRODUCTION
 
 
 
 
 
 
14.2
CAPSULES & TABLETS
 
 
 
 
 
 
 
 
ABILITY TO CATER TO DIVERSE CONSUMER NEEDS AND
 
 
 
 
 
14.3
POWDER & CRYSTALLINE
 
 
 
 
 
 
 
14.3.1
SURGING DEMAND FOR CUSTOMIZABLE DOSAGES AND HIGH PURITY TO PROPEL MARKET GROWTH
 
 
 
 
 
14.4
LIQUIDS
 
 
 
 
 
 
 
14.4.1
GROWING NEED FOR SUPPLEMENTS WITH ENHANCED BIOAVAILABILITY TO BOOST SEGMENT GROWTH
 
 
 
 
15
VITAMIN K2 MARKET, BY REGION
Comprehensive coverage of 8 Regions with country-level deep-dive of 12 Countries | 108 Data Tables.
 
 
 
 
 
139
 
15.1
INTRODUCTION
 
 
 
 
 
 
15.2
NORTH AMERICA
 
 
 
 
 
 
 
15.2.1
US
 
 
 
 
 
 
 
15.2.1.1
GROWING AWARENESS ABOUT PREVENTIVE HEALTH MEASURES TO DRIVE MARKET
 
 
 
 
 
15.2.2
CANADA
 
 
 
 
 
 
 
15.2.2.1
INCREASING FOCUS ON PREVENTIVE HEALTHCARE AND NATURAL PRODUCTS TO PROPEL MARKET
 
 
 
 
 
15.2.3
MEXICO
 
 
 
 
 
 
 
15.2.3.1
HIGH PREVALENCE OF CHRONIC LIFESTYLE DISEASES TO DRIVE MARKET
 
 
 
 
15.3
EUROPE
 
 
 
 
 
 
 
15.3.1
GERMANY
 
 
 
 
 
 
 
15.3.1.1
RISING FOCUS ON PROACTIVE HEALTHCARE TO DRIVE MARKET
 
 
 
 
 
15.3.2
FRANCE
 
 
 
 
 
 
 
15.3.2.1
INVESTMENTS IN R&D AND PRODUCT INNOVATION TO BOOST MARKET GROWTH
 
 
 
 
 
15.3.3
UK
 
 
 
 
 
 
 
15.3.3.1
RAPIDLY AGING POPULATION TO PROPEL MARKET GROWTH
 
 
 
 
 
15.3.4
ITALY
 
 
 
 
 
 
 
15.3.4.1
AGING POPULATION AND PREVENTIVE HEALTHCARE TRENDS TO SUPPORT VITAMIN K2 ADOPTION
 
 
 
 
 
15.3.5
SPAIN
 
 
 
 
 
 
 
15.3.5.1
GROWING CONSUMER INTEREST IN HEALTH SUPPLEMENTS TO DRIVE DEMAND
 
 
 
 
 
15.3.6
REST OF EUROPE
 
 
 
 
 
15.4
ASIA PACIFIC
 
 
 
 
 
 
 
15.4.1
CHINA
 
 
 
 
 
 
 
15.4.1.1
SURGING USE OF DIGITAL MEDIA TO DISSEMINATE HEALTHCARE INFORMATION TO PROPEL MARKET
 
 
 
 
 
15.4.2
JAPAN
 
 
 
 
 
 
 
15.4.2.1
CONSUMER PREFERENCES FOR NATURAL HEALTHCARE SOLUTIONS TO BOOST MARKET GROWTH
 
 
 
 
 
15.4.3
INDIA
 
 
 
 
 
 
 
15.4.3.1
STRATEGIC MARKET PENETRATION INITIATIVES BY VARIOUS COMPANIES TO DRIVE MARKET
 
 
 
 
 
15.4.4
AUSTRALIA AND NEW ZEALAND
 
 
 
 
 
 
 
15.4.4.1
CHANGING CONSUMER PREFERENCES AND INCREASING HEALTH CONSCIOUSNESS TO DRIVE DEMAND
 
 
 
 
 
15.4.5
REST OF ASIA PACIFIC
 
 
 
 
 
15.5
REST OF THE WORLD
 
 
 
 
 
 
 
15.5.1
SOUTH AMERICA
 
 
 
 
 
 
 
15.5.1.1
RISING PREVENTIVE HEALTHCARE AWARENESS AND EXPANDING NUTRACEUTICAL INDUSTRY TO SUPPORT MARKET GROWTH
 
 
 
 
 
15.5.2
MIDDLE EAST & AFRICA
 
 
 
 
 
 
 
15.5.2.1
RISING HEALTHCARE INVESTMENTS AND GROWING PREVENTIVE NUTRITION AWARENESS TO SUPPORT MARKET GROWTH
 
 
 
16
COMPETITIVE LANDSCAPE
Uncover top strategies driving key players' dominance and revenue growth in the competitive landscape.
 
 
 
 
 
176
 
16.1
OVERVIEW
 
 
 
 
 
 
16.2
KEY PLAYER COMPETITIVE STRATEGIES/RIGHT TO WIN 2021–2026
 
 
 
 
 
 
16.3
REVENUE ANALYSIS, 2023–2025
 
 
 
 
 
 
 
16.4
MARKET SHARE ANALYSIS, 2025
 
 
 
 
 
 
 
 
16.4.1
BRAND COMPARISON
 
 
 
 
 
 
16.4.2
NOVONESIS GROUP (MENAQUINGOLD)
 
 
 
 
 
 
16.4.3
GNOSIS BY LESAFFRE (MENAQ7)
 
 
 
 
 
 
16.4.4
BALCHEM CORP. (K2VITAL)
 
 
 
 
 
 
16.4.5
GUANGDONG SUNGEN BIOSCIENCE CO., LTD. (ESSEK2)
 
 
 
 
 
 
16.4.6
J-OIL MILLS, INC. (PLT HEALTH SOLUTIONS, INC.) (MENNATO)
 
 
 
 
 
16.5
COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025
 
 
 
 
 
 
 
 
16.5.1
STARS
 
 
 
 
 
 
16.5.2
EMERGING LEADERS
 
 
 
 
 
 
16.5.3
PERVASIVE PLAYERS
 
 
 
 
 
 
16.5.4
PARTICIPANTS
 
 
 
 
 
 
16.5.5
COMPANY FOOTPRINT: KEY PLAYERS, 2025
 
 
 
 
 
 
 
16.5.5.1
COMPANY FOOTPRINT
 
 
 
 
 
 
16.5.5.2
REGION FOOTPRINT
 
 
 
 
 
 
16.5.5.3
APPLICATION FOOTPRINT
 
 
 
 
 
 
16.5.5.4
PRODUCT TYPE FOOTPRINT
 
 
 
 
16.6
COMPANY EVALUATION MATRIX: DISTRIBUTORS/SUPPLIERS
 
 
 
 
 
 
 
 
16.6.1
PROGRESSIVE COMPANIES
 
 
 
 
 
 
16.6.2
RESPONSIVE COMPANIES
 
 
 
 
 
 
16.6.3
DYNAMIC COMPANIES
 
 
 
 
 
 
16.6.4
STARTING BLOCKS
 
 
 
 
 
 
16.6.5
COMPETITIVE BENCHMARKING: DISTRIBUTORS/SUPPLIERS, 2025
 
 
 
 
 
 
 
16.6.5.1
DETAILED LIST OF KEY DISTRIBUTORS/SUPPLIERS
 
 
 
 
 
 
16.6.5.2
COMPETITIVE BENCHMARKING OF KEY DISTRIBUTORS/SUPPLIERS
 
 
 
 
16.7
COMPANY VALUATION AND FINANCIAL METRICS
 
 
 
 
 
 
 
16.7.1
COMPANY VALUATION
 
 
 
 
 
 
16.7.2
EV/EBITDA
 
 
 
 
 
16.8
COMPETITIVE SCENARIO
 
 
 
 
 
 
 
16.8.1
PRODUCT LAUNCHES/DEVELOPMENTS
 
 
 
 
 
 
16.8.2
DEALS
 
 
 
 
 
 
16.8.3
EXPANSIONS
 
 
 
 
 
 
16.8.4
OTHER DEVELOPMENTS
 
 
 
 
17
COMPANY PROFILES
In-depth Company Profiles of Leading Market Players with detailed Business Overview, Product and Service Portfolio, Recent Developments, and Unique Analyst Perspective (MnM View)
 
 
 
 
 
199
 
17.1
KEY PLAYERS (MANUFACTURERS)
 
 
 
 
 
 
 
17.1.1
GNOSIS BY LESAFFRE
 
 
 
 
 
 
 
17.1.1.1
BUSINESS OVERVIEW
 
 
 
 
 
 
17.1.1.2
PRODUCTS/SOLUTIONS/SERVICES OFFERED
 
 
 
 
 
 
17.1.1.3
RECENT DEVELOPMENTS
 
 
 
 
 
 
 
 
17.1.1.3.1
PRODUCT LAUNCHES/DEVELOPMENTS
 
 
 
 
 
 
17.1.1.3.2
DEALS
 
 
 
 
17.1.1.4
MNM VIEW
 
 
 
 
 
 
 
 
17.1.1.4.1
RIGHT TO WIN
 
 
 
 
 
 
17.1.1.4.2
STRATEGIC CHOICES
 
 
 
 
 
 
17.1.1.4.3
WEAKNESSES AND COMPETITIVE THREATS
 
 
 
17.1.2
BALCHEM CORP.
 
 
 
 
 
 
17.1.3
J-OIL MILLS, INC. (PLT HEALTH SOLUTIONS, INC.)
 
 
 
 
 
 
17.1.4
NOVONESIS GROUP
 
 
 
 
 
 
17.1.5
GUANGDONG SUNGEN BIOSCIENCE CO., LTD.
 
 
 
 
 
 
17.1.6
VESTA NUTRA
 
 
 
 
 
 
17.1.7
RICHEN NUTRITIONAL TECHNOLOGY CO., LTD.
 
 
 
 
 
 
17.1.8
MENADIONA
 
 
 
 
 
 
17.1.9
GF FERMENTECH CO., LTD.
 
 
 
 
 
 
17.1.10
ANGELYEAST CO., LTD.
 
 
 
 
 
 
17.1.11
GENEFERM BIOTECHNOLOGY CO., LTD.
 
 
 
 
 
 
17.1.12
NAKODA CHEMICALS LTD.
 
 
 
 
 
 
17.1.13
HAIHANG INDUSTRY CO., LTD.
 
 
 
 
 
 
17.1.14
CHEMICEA LIMITED
 
 
 
 
 
 
17.1.15
KYOWA HAKKO U.S.A., INC.
 
 
 
 
 
17.2
DISTRIBUTORS/SUPPLIERS
 
 
 
 
 
 
 
17.2.1
SEEBIO BIOTECH (SHANGHAI) CO., LTD.
 
 
 
 
 
 
17.2.2
MAGNESIA GMBH
 
 
 
 
 
 
17.2.3
FALCON TRADING INTERNATIONAL
 
 
 
 
 
 
17.2.4
ABCO INDIA
 
 
 
 
 
 
17.2.5
ATLANTIC CHEMICALS TRADING GMBH
 
 
 
 
18
RESEARCH METHODOLOGY
 
 
 
 
 
244
 
18.1
RESEARCH DATA
 
 
 
 
 
 
 
18.1.1
SECONDARY DATA
 
 
 
 
 
 
 
18.1.1.1
KEY DATA FROM SECONDARY SOURCES
 
 
 
 
 
18.1.2
PRIMARY DATA
 
 
 
 
 
 
 
18.1.2.1
KEY DATA FROM PRIMARY SOURCES
 
 
 
 
 
 
18.1.2.2
BREAKDOWN OF PRIMARY PROFILES
 
 
 
 
 
 
18.1.2.3
KEY INSIGHTS FROM INDUSTRY EXPERTS
 
 
 
 
18.2
MARKET SIZE ESTIMATION
 
 
 
 
 
 
 
18.2.1
TOP-DOWN APPROACH
 
 
 
 
 
 
18.2.2
SUPPLY-SIDE ANALYSIS
 
 
 
 
 
 
18.2.3
BOTTOM-UP APPROACH (DEMAND SIDE)
 
 
 
 
 
18.3
DATA TRIANGULATION AND MARKET BREAKUP
 
 
 
 
 
 
18.4
RESEARCH ASSUMPTIONS
 
 
 
 
 
 
18.5
RESEARCH LIMITATIONS AND RISK ASSESSMENT
 
 
 
 
 
19
ADJACENT AND RELATED MARKETS
 
 
 
 
 
254
 
19.1
INTRODUCTION
 
 
 
 
 
 
19.2
RESEARCH LIMITATIONS
 
 
 
 
 
 
19.3
DIETARY SUPPLEMENTS MARKET
 
 
 
 
 
 
 
19.3.1
MARKET DEFINITION
 
 
 
 
 
 
19.3.2
MARKET OVERVIEW
 
 
 
 
 
19.4
VITAMINS MARKET
 
 
 
 
 
 
 
19.4.1
MARKET DEFINITION
 
 
 
 
 
 
19.4.2
MARKET OVERVIEW
 
 
 
 
20
APPENDIX
 
 
 
 
 
258
 
20.1
DISCUSSION GUIDE
 
 
 
 
 
 
20.2
KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
 
 
 
 
 
 
20.3
CUSTOMIZATION OPTIONS
 
 
 
 
 
 
20.4
RELATED REPORTS
 
 
 
 
 
 
20.5
AUTHOR DETAILS
 
 
 
 
 
LIST OF TABLES
 
 
 
 
 
 
 
TABLE 1
INCLUSIONS AND EXCLUSIONS
 
 
 
 
 
 
TABLE 2
USD EXCHANGE RATES, 2022–2025
 
 
 
 
 
 
TABLE 3
IMPACT OF PORTER’S FIVE FORCES ON VITAMIN K2 MARKET
 
 
 
 
 
 
TABLE 4
VITAMIN K2 MARKET: SUPPLY SIDE (ECOSYSTEM)
 
 
 
 
 
 
TABLE 5
AVERAGE SELLING PRICE (ASP) TREND, BY PRODUCT TYPE, 2022–2025 (USD/TONS)
 
 
 
 
 
 
TABLE 6
AVERAGE SELLING PRICE (ASP) TREND, BY REGION, 2022–2025 (USD/TONS)
 
 
 
 
 
 
TABLE 7
TOP IMPORTERS OF VITAMINS AND THEIR DERIVATIVES, 2021–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 8
TOP EXPORTERS OF VITAMINS AND THEIR DERIVATIVES, 2021–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 9
VITAMIN K2 MARKET: LIST OF KEY CONFERENCES AND EVENTS, 2026–2027
 
 
 
 
 
 
TABLE 10
PATENTS PERTAINING TO VITAMIN K2 MARKET, 2024–2026
 
 
 
 
 
 
TABLE 11
VITAMIN K2 MARKET: CASE STUDIES RELATED TO GENERATIVE AI IMPLEMENTATION
 
 
 
 
 
 
TABLE 12
INTERCONNECTED ADJACENT ECOSYSTEM AND IMPACT ON MARKET PLAYERS
 
 
 
 
 
 
TABLE 13
NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
 
 
TABLE 14
EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
 
 
TABLE 15
ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
 
 
TABLE 16
INTERNATIONAL: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
 
 
TABLE 17
GLOBAL INDUSTRY STANDARDS IN VITAMIN K2 MARKET
 
 
 
 
 
 
TABLE 18
LABELING REQUIREMENTS AND CLAIMS IN VITAMIN K2 MARKET
 
 
 
 
 
 
TABLE 19
CERTIFICATIONS, LABELING, AND ECO-STANDARDS IN VITAMIN K2 MARKET
 
 
 
 
 
 
TABLE 20
INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR VITAMIN K2 PRODUCT TYPES
 
 
 
 
 
 
TABLE 21
KEY BUYING CRITERIA FOR VITAMIN K2 PRODUCT TYPES
 
 
 
 
 
 
TABLE 22
UNMET NEEDS IN VITAMIN K2 MARKET, BY APPLICATION INDUSTRIES ACROSS SUPPLY CHAIN
 
 
 
 
 
 
TABLE 23
COST DYNAMICS IN VITAMIN K2 MARKET
 
 
 
 
 
 
TABLE 24
MARGIN OPPORTUNITIES IN VITAMIN K2 MARKET, BY PRODUCT TYPE
 
 
 
 
 
 
TABLE 25
PRODUCTION TECHNOLOGY APPLIED BY KEY PLAYERS
 
 
 
 
 
 
TABLE 26
PRODUCT TYPE: OVERVIEW
 
 
 
 
 
 
TABLE 27
VITAMIN K2 MARKET, BY PRODUCT TYPE, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 28
VITAMIN K2 MARKET, BY PRODUCT TYPE, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 29
VITAMIN K2 MARKET, BY PRODUCT TYPE, 2022–2025 (TON)
 
 
 
 
 
 
TABLE 30
VITAMIN K2 MARKET, BY PRODUCT TYPE, 2026–2031 (TON)
 
 
 
 
 
 
TABLE 31
MK7: VITAMIN K2 MARKET, BY APPLICATION, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 32
MK7: VITAMIN K2 MARKET, BY APPLICATION, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 33
MK7: VITAMIN K2 MARKET, BY REGION, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 34
MK7: VITAMIN K2 MARKET, BY REGION, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 35
MK7: VITAMIN K2 MARKET, BY REGION, 2022–2025 (TON)
 
 
 
 
 
 
TABLE 36
MK7: VITAMIN K2 MARKET, BY REGION, 2026–2031 (TON)
 
 
 
 
 
 
TABLE 37
MK4: VITAMIN K2 MARKET, BY APPLICATION, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 38
MK4: VITAMIN K2 MARKET, BY APPLICATION, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 39
MK4: VITAMIN K2 MARKET, BY REGION, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 40
MK4: VITAMIN K2 MARKET, BY REGION, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 41
MK4: VITAMIN K2 MARKET, BY REGION, 2022–2025 (TON)
 
 
 
 
 
 
TABLE 42
MK4: VITAMIN K2 MARKET, BY REGION, 2026–2031 (TON)
 
 
 
 
 
 
TABLE 43
VITAMIN K2 MARKET, BY SOURCE, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 44
VITAMIN K2 MARKET, BY SOURCE, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 45
NATURAL: VITAMIN K2 MARKET, BY REGION, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 46
NATURAL: VITAMIN K2 MARKET, BY REGION, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 47
SYNTHETIC: VITAMIN K2 MARKET, BY REGION, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 48
SYNTHETIC: VITAMIN K2 MARKET, BY REGION, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 49
VITAMIN K2 MARKET, BY APPLICATION, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 50
VITAMIN K2 MARKET, BY APPLICATION, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 51
HEALTH SUPPLEMENTS: VITAMIN K2 MARKET, BY REGION, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 52
HEALTH SUPPLEMENTS: VITAMIN K2 MARKET, BY REGION, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 53
HEALTH SUPPLEMENTS: MK7 VITAMIN K2 MARKET, BY REGION, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 54
HEALTH SUPPLEMENTS: MK7 VITAMIN K2 MARKET, BY REGION, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 55
HEALTH SUPPLEMENTS: MK4 VITAMIN K2 MARKET, BY REGION, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 56
HEALTH SUPPLEMENTS: MK4 VITAMIN K2 MARKET, BY REGION, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 57
FUNCTIONAL FOOD & BEVERAGES: VITAMIN K2 MARKET, BY REGION, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 58
FUNCTIONAL FOOD & BEVERAGES: VITAMIN K2 MARKET, BY REGION, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 59
FUNCTIONAL FOOD & BEVERAGES: MK7 VITAMIN K2 MARKET, BY REGION, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 60
FUNCTIONAL FOOD & BEVERAGES: MK7 VITAMIN K2 MARKET, BY REGION, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 61
FUNCTIONAL FOOD & BEVERAGES: MK4 VITAMIN K2 MARKET, BY REGION, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 62
FUNCTIONAL FOOD & BEVERAGES: MK4 VITAMIN K2 MARKET, BY REGION, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 63
PHARMACEUTICALS: VITAMIN K2 MARKET, BY REGION, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 64
PHARMACEUTICALS: VITAMIN K2 MARKET, BY REGION, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 65
PHARMACEUTICALS: MK7 VITAMIN K2 MARKET, BY REGION, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 66
PHARMACEUTICALS: MK7 VITAMIN K2 MARKET, BY REGION, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 67
PHARMACEUTICALS: MK4 VITAMIN K2 MARKET, BY REGION, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 68
PHARMACEUTICALS: MK4 VITAMIN K2 MARKET, BY REGION, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 69
VITAMIN K2 MARKET, BY APPLICATION FORM, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 70
VITAMIN K2 MARKET, BY APPLICATION FORM, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 71
CAPSULES & TABLETS: VITAMIN K2 MARKET, BY REGION, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 72
CAPSULES & TABLETS: VITAMIN K2 MARKET, BY REGION, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 73
POWDER & CRYSTALLINE: VITAMIN K2 MARKET, BY REGION, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 74
POWDER & CRYSTALLINE: VITAMIN K2 MARKET, BY REGION, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 75
LIQUIDS: VITAMIN K2 MARKET, BY REGION, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 76
LIQUIDS: VITAMIN K2 MARKET, BY REGION, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 77
VITAMIN K2 MARKET, BY REGION, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 78
VITAMIN K2 MARKET, BY REGION, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 79
VITAMIN K2 MARKET, BY REGION, 2022–2025 (TON)
 
 
 
 
 
 
TABLE 80
VITAMIN K2 MARKET, BY REGION, 2026–2031 (TON)
 
 
 
 
 
 
TABLE 81
NORTH AMERICA: VITAMIN K2 MARKET, BY COUNTRY, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 82
NORTH AMERICA: VITAMIN K2 MARKET, BY COUNTRY, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 83
NORTH AMERICA: VITAMIN K2 MARKET, BY COUNTRY, 2022–2025 (TON)
 
 
 
 
 
 
TABLE 84
NORTH AMERICA: VITAMIN K2 MARKET, BY COUNTRY, 2026–2031 (TON)
 
 
 
 
 
 
TABLE 85
NORTH AMERICA: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 86
NORTH AMERICA: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 87
NORTH AMERICA: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2022–2025 (TON)
 
 
 
 
 
 
TABLE 88
NORTH AMERICA: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2026–2031 (TON)
 
 
 
 
 
 
TABLE 89
NORTH AMERICA: VITAMIN K2 MARKET, BY APPLICATION FORM, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 90
NORTH AMERICA: VITAMIN K2 MARKET, BY APPLICATION FORM, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 91
NORTH AMERICA: VITAMIN K2 MARKET, BY SOURCE, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 92
NORTH AMERICA: VITAMIN K2 MARKET, BY SOURCE, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 93
NORTH AMERICA: VITAMIN K2 MARKET, BY APPLICATION, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 94
NORTH AMERICA: VITAMIN K2 MARKET, BY APPLICATION, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 95
NORTH AMERICA: MK7 VITAMIN K2 MARKET, BY APPLICATION, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 96
NORTH AMERICA: MK7 VITAMIN K2 MARKET, BY APPLICATION, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 97
NORTH AMERICA: MK4 VITAMIN K2 MARKET, BY APPLICATION, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 98
NORTH AMERICA: MK4 VITAMIN K2 MARKET, BY APPLICATION, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 99
US: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 100
US: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 101
CANADA: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 102
CANADA: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 103
MEXICO: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 104
MEXICO: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 105
EUROPE: VITAMIN K2 MARKET, BY COUNTRY, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 106
EUROPE: VITAMIN K2 MARKET, BY COUNTRY, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 107
EUROPE: VITAMIN K2 MARKET, BY COUNTRY, 2022–2025 (TON)
 
 
 
 
 
 
TABLE 108
EUROPE: VITAMIN K2 MARKET, BY COUNTRY, 2026–2031 (TON)
 
 
 
 
 
 
TABLE 109
EUROPE: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 110
EUROPE: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 111
EUROPE: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2022–2025 (TON)
 
 
 
 
 
 
TABLE 112
EUROPE: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2026–2031 (TON)
 
 
 
 
 
 
TABLE 113
EUROPE: VITAMIN K2 MARKET, BY APPLICATION FORM, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 114
EUROPE: VITAMIN K2 MARKET, BY APPLICATION FORM, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 115
EUROPE: VITAMIN K2 MARKET, BY SOURCE, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 116
EUROPE: VITAMIN K2 MARKET, BY SOURCE, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 117
EUROPE: VITAMIN K2 MARKET, BY APPLICATION, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 118
EUROPE: VITAMIN K2 MARKET, BY APPLICATION, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 119
EUROPE: MK7 VITAMIN K2 MARKET, BY APPLICATION, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 120
EUROPE: MK7 VITAMIN K2 MARKET, BY APPLICATION, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 121
EUROPE: MK4 VITAMIN K2 MARKET, BY APPLICATION, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 122
EUROPE: MK4 VITAMIN K2 MARKET, BY APPLICATION, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 123
GERMANY: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 124
GERMANY: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 125
FRANCE: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 126
FRANCE: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 127
UK: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 128
UK: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 129
ITALY: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 130
ITALY: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 131
SPAIN: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 132
SPAIN: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 133
REST OF EUROPE: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 134
REST OF EUROPE: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 135
ASIA PACIFIC: VITAMIN K2 MARKET, BY COUNTRY, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 136
ASIA PACIFIC: VITAMIN K2 MARKET, BY COUNTRY, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 137
ASIA PACIFIC: VITAMIN K2 MARKET, BY COUNTRY, 2022–2025 (TON)
 
 
 
 
 
 
TABLE 138
ASIA PACIFIC: VITAMIN K2 MARKET, BY COUNTRY, 2026–2031 (TON)
 
 
 
 
 
 
TABLE 139
ASIA PACIFIC: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 140
ASIA PACIFIC: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 141
ASIA PACIFIC: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2022–2025 (TON)
 
 
 
 
 
 
TABLE 142
ASIA PACIFIC: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2026–2031 (TON)
 
 
 
 
 
 
TABLE 143
ASIA PACIFIC: VITAMIN K2 MARKET, BY APPLICATION FORM, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 144
ASIA PACIFIC: VITAMIN K2 MARKET, BY APPLICATION FORM, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 145
ASIA PACIFIC: VITAMIN K2 MARKET, BY SOURCE, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 146
ASIA PACIFIC: VITAMIN K2 MARKET, BY SOURCE, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 147
ASIA PACIFIC: VITAMIN K2 MARKET, BY APPLICATION, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 148
ASIA PACIFIC: VITAMIN K2 MARKET, BY APPLICATION, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 149
ASIA PACIFIC: MK7 VITAMIN K2 MARKET, BY APPLICATION, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 150
ASIA PACIFIC: MK7 VITAMIN K2 MARKET, BY APPLICATION, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 151
ASIA PACIFIC: MK4 VITAMIN K2 MARKET, BY APPLICATION, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 152
ASIA PACIFIC: MK4 VITAMIN K2 MARKET, BY APPLICATION, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 153
CHINA: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 154
CHINA: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 155
JAPAN: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 156
JAPAN: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 157
INDIA: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 158
INDIA: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 159
AUSTRALIA AND NEW ZEALAND: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 160
AUSTRALIA AND NEW ZEALAND: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 161
REST OF ASIA PACIFIC: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 162
REST OF ASIA PACIFIC: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 163
REST OF THE WORLD: VITAMIN K2 MARKET, BY REGION, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 164
REST OF THE WORLD: VITAMIN K2 MARKET, BY REGION, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 165
REST OF THE WORLD: VITAMIN K2 MARKET, BY REGION, 2022–2025 (TON)
 
 
 
 
 
 
TABLE 166
REST OF THE WORLD: VITAMIN K2 MARKET, BY REGION, 2026–2031 (TON)
 
 
 
 
 
 
TABLE 167
REST OF THE WORLD: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 168
REST OF THE WORLD: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 169
REST OF THE WORLD: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2022–2025 (TON)
 
 
 
 
 
 
TABLE 170
REST OF THE WORLD: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2026–2031 (TON)
 
 
 
 
 
 
TABLE 171
REST OF THE WORLD: VITAMIN K2 MARKET, BY APPLICATION FORM, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 172
REST OF THE WORLD: VITAMIN K2 MARKET, BY APPLICATION FORM, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 173
REST OF THE WORLD: VITAMIN K2 MARKET, BY SOURCE, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 174
REST OF THE WORLD: VITAMIN K2 MARKET, BY SOURCE, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 175
REST OF THE WORLD: VITAMIN K2 MARKET, BY APPLICATION, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 176
REST OF THE WORLD: VITAMIN K2 MARKET, BY APPLICATION, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 177
REST OF THE WORLD: MK7 VITAMIN K2 MARKET, BY APPLICATION, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 178
REST OF THE WORLD: MK7 VITAMIN K2 MARKET, BY APPLICATION, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 179
REST OF THE WORLD: MK4 VITAMIN K2 MARKET, BY APPLICATION, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 180
REST OF THE WORLD: MK4 VITAMIN K2 MARKET, BY APPLICATION, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 181
SOUTH AMERICA: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 182
SOUTH AMERICA: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 183
MIDDLE EAST & AFRICA: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2022–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 184
MIDDLE EAST & AFRICA: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2026–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 185
OVERVIEW OF STRATEGIES ADOPTED BY KEY VITAMIN K2 VENDORS, 2021–2026
 
 
 
 
 
 
TABLE 186
VITAMIN K2 MARKET: DEGREE OF COMPETITION
 
 
 
 
 
 
TABLE 187
VITAMIN K2 MARKET: REGION FOOTPRINT
 
 
 
 
 
 
TABLE 188
VITAMIN K2 MARKET: APPLICATION FOOTPRINT
 
 
 
 
 
 
TABLE 189
VITAMIN K2 MARKET: PRODUCT TYPE FOOTPRINT
 
 
 
 
 
 
TABLE 190
VITAMIN K2 MARKET: KEY DISTRIBUTORS/SUPPLIERS, 2025
 
 
 
 
 
 
TABLE 191
VITAMIN K2 MARKET: COMPETITIVE BENCHMARKING OF KEY DISTRIBUTORS/SUPPLIERS
 
 
 
 
 
 
TABLE 192
VITAMIN K2 MARKET: PRODUCT LAUNCHES/DEVELOPMENTS, 2021–JUNE 2026
 
 
 
 
 
 
TABLE 193
VITAMIN K2 MARKET: DEALS, 2021–JUNE 2026
 
 
 
 
 
 
TABLE 194
VITAMIN K2 MARKET: EXPANSIONS, 2021–JUNE 2026
 
 
 
 
 
 
TABLE 195
VITAMIN K2 MARKET: OTHER DEVELOPMENTS, 2021–JUNE 2026
 
 
 
 
 
 
TABLE 196
GNOSIS BY LESAFFRE: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 197
GNOSIS BY LESAFFRE: PRODUCTS/SOLUTIONS/SERVICES OFFERED
 
 
 
 
 
 
TABLE 198
GNOSIS BY LESAFFRE: PRODUCT LAUNCHES/DEVELOPMENTS
 
 
 
 
 
 
TABLE 199
GNOSIS BY LESAFFRE: DEALS
 
 
 
 
 
 
TABLE 200
BALCHEM CORP.: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 201
BALCHEM CORP.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
 
 
 
 
 
 
TABLE 202
BALCHEM CORP.: PRODUCT LAUNCHES/DEVELOPMENTS
 
 
 
 
 
 
TABLE 203
BALCHEM CORP.: DEALS
 
 
 
 
 
 
TABLE 204
BALCHEM CORP.: EXPANSIONS
 
 
 
 
 
 
TABLE 205
J-OIL MILLS, INC. (PLT HEALTH SOLUTIONS, INC.): COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 206
J-OIL MILLS, INC. (PLT HEALTH SOLUTIONS, INC.): PRODUCTS/SOLUTIONS/ SERVICES OFFERED
 
 
 
 
 
 
TABLE 207
J-OIL MILLS, INC. (PLT HEALTH SOLUTIONS, INC.): PRODUCT LAUNCHES/DEVELOPMENTS
 
 
 
 
 
 
TABLE 208
J-OIL MILLS, INC. (PLT HEALTH SOLUTIONS, INC.): DEALS
 
 
 
 
 
 
TABLE 209
NOVONESIS GROUP: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 210
NOVONESIS GROUP: PRODUCTS/SOLUTIONS/SERVICES OFFERED
 
 
 
 
 
 
TABLE 211
NOVONESIS GROUP: DEALS
 
 
 
 
 
 
TABLE 212
GUANGDONG SUNGEN BIOSCIENCE CO., LTD.: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 213
GUANGDONG SUNGEN BIOSCIENCE CO., LTD.: PRODUCTS/SOLUTIONS/ SERVICES OFFERED
 
 
 
 
 
 
TABLE 214
GUANGDONG SUNGEN BIOSCIENCE CO., LTD.: OTHER DEVELOPMENTS
 
 
 
 
 
 
TABLE 215
VESTA NUTRA: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 216
VESTA NUTRA: PRODUCTS/SOLUTIONS/SERVICES OFFERED
 
 
 
 
 
 
TABLE 217
RICHEN NUTRITIONAL TECHNOLOGY CO., LTD.: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 218
RICHEN NUTRITIONAL TECHNOLOGY CO., LTD.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
 
 
 
 
 
 
TABLE 219
RICHEN NUTRITIONAL TECHNOLOGY CO., LTD.: PRODUCT LAUNCHES/DEVELOPMENTS
 
 
 
 
 
 
TABLE 220
RICHEN NUTRITIONAL TECHNOLOGY CO., LTD.: OTHER DEVELOPMENTS
 
 
 
 
 
 
TABLE 221
MENADIONA: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 222
MENADIONA: PRODUCTS/SOLUTIONS/SERVICES OFFERED
 
 
 
 
 
 
TABLE 223
MENADIONA: PRODUCT LAUNCHES/DEVELOPMENTS
 
 
 
 
 
 
TABLE 224
GF FERMENTECH CO., LTD.: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 225
GF FERMENTECH CO., LTD.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
 
 
 
 
 
 
TABLE 226
GF FERMENTECH CO., LTD.: PRODUCT LAUNCHES/DEVELOPMENTS
 
 
 
 
 
 
TABLE 227
GF FERMENTECH CO., LTD.: DEALS
 
 
 
 
 
 
TABLE 228
ANGELYEAST CO., LTD.: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 229
ANGELYEAST CO., LTD.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
 
 
 
 
 
 
TABLE 230
ANGELYEAST CO., LTD.: EXPANSIONS
 
 
 
 
 
 
TABLE 231
GENEFERM BIOTECHNOLOGY CO., LTD.: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 232
GENEFERM BIOTECHNOLOGY CO., LTD.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
 
 
 
 
 
 
TABLE 233
GENEFERM BIOTECHNOLOGY CO., LTD.: EXPANSIONS
 
 
 
 
 
 
TABLE 234
NAKODA CHEMICALS LTD.: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 235
NAKODA CHEMICALS LTD.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
 
 
 
 
 
 
TABLE 236
HAIHANG INDUSTRY CO., LTD.: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 237
HAIHANG INDUSTRY CO., LTD.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
 
 
 
 
 
 
TABLE 238
CHEMICEA LIMITED: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 239
CHEMICEA LIMITED: PRODUCTS/SOLUTIONS/SERVICES OFFERED
 
 
 
 
 
 
TABLE 240
KYOWA HAKKO U.S.A., INC.: BUSINESS OVERVIEW
 
 
 
 
 
 
TABLE 241
KYOWA HAKKO U.S.A., INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
 
 
 
 
 
 
TABLE 242
SEEBIO BIOTECH (SHANGHAI) CO., LTD.: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 243
MAGNESIA GMBH: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 244
FALCON TRADING INTERNATIONAL: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 245
ABCO INDIA: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 246
ATLANTIC CHEMICALS TRADING GMBH: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 247
MARKETS ADJACENT TO VITAMIN K2 MARKET
 
 
 
 
 
 
TABLE 248
DIETARY SUPPLEMENTS MARKET, BY MODE OF APPLICATION, 2020–2023 (USD MILLION)
 
 
 
 
 
 
TABLE 249
DIETARY SUPPLEMENTS MARKET, BY MODE OF APPLICATION, 2024–2029 (USD MILLION)
 
 
 
 
 
 
TABLE 250
VITAMINS MARKET, BY SOURCE, 2017–2022 (USD MILLION)
 
 
 
 
 
 
TABLE 251
VITAMINS MARKET, BY SOURCE, 2023–2028 (USD MILLION)
 
 
 
 
 
 
LIST OF FIGURES
 
 
 
 
 
 
 
FIGURE 1
MARKET SCENARIO
 
 
 
 
 
 
FIGURE 2
VITAMIN K2 MARKET, 2022–2031
 
 
 
 
 
 
FIGURE 3
MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN VITAMIN K2, 2022–JUNE 2026
 
 
 
 
 
 
FIGURE 4
DISRUPTIONS INFLUENCING GROWTH OF VITAMIN K2 MARKET
 
 
 
 
 
 
FIGURE 5
VITAMIN K2 MARKET: HIGH-GROWTH SEGMENTS, 2026–2031
 
 
 
 
 
 
FIGURE 6
ASIA PACIFIC TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD
 
 
 
 
 
 
FIGURE 7
RISING DEMAND FOR PREVENTIVE HEALTHCARE AND NATURALLY FERMENTED VITAMIN K2 TO CREATE LUCRATIVE OPPORTUNITIES FOR MARKET PLAYERS
 
 
 
 
 
 
FIGURE 8
CAPSULES & TABLETS SEGMENT AND NORTH AMERICA TO ACCOUNT FOR LARGEST MARKET SHARES IN 2026
 
 
 
 
 
 
FIGURE 9
NATURAL SEGMENT TO DOMINATE MARKET IN 2026
 
 
 
 
 
 
FIGURE 10
HEALTH SUPPLEMENTS SEGMENT TO ACCOUNT FOR LARGEST MARKET SHARE IN 2026
 
 
 
 
 
 
FIGURE 11
MK7 SEGMENT TO DOMINATE MARKET IN 2026
 
 
 
 
 
 
FIGURE 12
CAPSULES & TABLETS SEGMENT TO ACCOUNT FOR LARGEST MARKET SHARE IN 2026
 
 
 
 
 
 
FIGURE 13
US TO ACCOUNT FOR LARGEST MARKET SHARE IN 2026
 
 
 
 
 
 
FIGURE 14
VITAMIN K2 MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
 
 
 
 
 
 
FIGURE 15
HEALTH EXPENDITURE AS SHARE OF GDP FOR SELECTED COUNTRIES, 2014–2024
 
 
 
 
 
 
FIGURE 16
VITAMIN K2 MARKET: PORTER’S FIVE FORCES ANALYSIS
 
 
 
 
 
 
FIGURE 17
GDP TRENDS AND FORECAST OF MAJOR ECONOMIES, 2023–2030 (USD BILLION)
 
 
 
 
 
 
FIGURE 18
GLOBAL POPULATION GROWTH, 2000–2100 (BILLION)
 
 
 
 
 
 
FIGURE 19
GLOBAL TRENDS IN DEATHS DUE TO CVD, 1990–2030
 
 
 
 
 
 
FIGURE 20
VITAMIN K2 MARKET: VALUE CHAIN ANALYSIS
 
 
 
 
 
 
FIGURE 21
VITAMIN K2 MARKET: ECOSYSTEM ANALYSIS
 
 
 
 
 
 
FIGURE 22
AVERAGE SELLING PRICE (ASP) TREND, BY REGION, 2022–2025 (USD/TONS)
 
 
 
 
 
 
FIGURE 23
IMPORT OF HS CODE 293629, BY KEY COUNTRY, 2021–2025 (USD MILLION)
 
 
 
 
 
 
FIGURE 24
EXPORT OF HS CODE 293629, BY KEY COUNTRY, 2021–2025, (USD MILLION)
 
 
 
 
 
 
FIGURE 25
TRENDS/DISRUPTIONS INFLUENCING CUSTOMER BUSINESS
 
 
 
 
 
 
FIGURE 26
INVESTMENT AND FUNDING SCENARIO
 
 
 
 
 
 
FIGURE 27
NUMBER OF PATENTS APPLIED AND GRANTED, 2016–2026
 
 
 
 
 
 
FIGURE 28
FUTURE APPLICATIONS
 
 
 
 
 
 
FIGURE 29
VITAMIN K2 MARKET DECISION-MAKING FACTORS
 
 
 
 
 
 
FIGURE 30
INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR VITAMIN K2 PRODUCT TYPES
 
 
 
 
 
 
FIGURE 31
KEY BUYING CRITERIA FOR VITAMIN K2 PRODUCT TYPES
 
 
 
 
 
 
FIGURE 32
ADOPTION BARRIERS AND INTERNAL CHALLENGES
 
 
 
 
 
 
FIGURE 33
VITAMIN K2 MARKET, BY PRODUCT TYPE, 2026 VS. 2031
 
 
 
 
 
 
FIGURE 34
VITAMIN K2 MARKET, BY SOURCE, 2026 VS. 2031
 
 
 
 
 
 
FIGURE 35
VITAMIN K2 MARKET, BY APPLICATION, 2026 VS. 2031
 
 
 
 
 
 
FIGURE 36
VITAMIN K2 MARKET, BY APPLICATION FORM, 2026 VS. 2031
 
 
 
 
 
 
FIGURE 37
ITALY TO RECORD HIGHEST GROWTH RATE DURING FORECAST PERIOD
 
 
 
 
 
 
FIGURE 38
NORTH AMERICA: VITAMIN K2 MARKET SNAPSHOT
 
 
 
 
 
 
FIGURE 39
ASIA PACIFIC: VITAMIN K2 MARKET SNAPSHOT
 
 
 
 
 
 
FIGURE 40
REVENUE ANALYSIS OF KEY COMPANIES, 2023–2025 (USD BILLION)
 
 
 
 
 
 
FIGURE 41
SHARE OF LEADING COMPANIES IN VITAMIN K2 MARKET, 2025
 
 
 
 
 
 
FIGURE 42
COMPARATIVE ANALYSIS OF VENDOR BRANDS
 
 
 
 
 
 
FIGURE 43
VITAMIN K2 MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2025
 
 
 
 
 
 
FIGURE 44
VITAMIN K2 MARKET: COMPANY FOOTPRINT
 
 
 
 
 
 
FIGURE 45
VITAMIN K2 MARKET: COMPANY EVALUATION MATRIX (DISTRIBUTORS/SUPPLIERS), 2025
 
 
 
 
 
 
FIGURE 46
COMPANY VALUATION OF KEY VITAMIN K2 VENDORS
 
 
 
 
 
 
FIGURE 47
EV/EBITDA OF KEY COMPANIES
 
 
 
 
 
 
FIGURE 48
BALCHEM CORP.: COMPANY SNAPSHOT
 
 
 
 
 
 
FIGURE 49
J-OIL MILLS, INC. (PLT HEALTH SOLUTIONS, INC.): COMPANY SNAPSHOT
 
 
 
 
 
 
FIGURE 50
NOVONESIS GROUP: COMPANY SNAPSHOT
 
 
 
 
 
 
FIGURE 51
GENEFERM BIOTECHNOLOGY CO., LTD.: COMPANY SNAPSHOT
 
 
 
 
 
 
FIGURE 52
VITAMIN K2 MARKET: RESEARCH DESIGN
 
 
 
 
 
 
FIGURE 53
BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
 
 
 
 
 
 
FIGURE 54
MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
 
 
 
 
 
 
FIGURE 55
SUPPLY-SIDE ANALYSIS: SOURCES OF INFORMATION AT EVERY STEP
 
 
 
 
 
 
FIGURE 56
VITAMIN K2 MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH
 
 
 
 
 
 
FIGURE 57
DATA TRIANGULATION
 
 
 
 
 
 

Methodology

This study employed two primary approaches to estimate the current size of the vitamin K2 market. Exhaustive secondary research was carried out to collect information on the product type, function (qualitative), source, application, application form and processing technology (qualitative) of the market. The next step involved validating these findings, assumptions, and sizing with industry experts across the value chain through primary research. Top-down and bottom-up approaches were employed to estimate the complete market size. Thereafter, data triangulation was used to estimate the market size of segments and subsegments.

Secondary Research

This research study used extensive secondary sources—directories and databases such as Bloomberg Businessweek and Factiva—to identify and collect information for a technical, market-oriented, and commercial market study. In the secondary research process, sources such as annual reports, press releases & investor presentations of companies, white papers, vitamin K2 and health supplements-related journals, certified publications, articles from recognized authors, directories, and databases were referred to identify and collect information. Secondary research was mainly used to obtain key information about the industry’s supply chain, the pool of key players, and market classification and segmentation based on the industry trends to the bottom-most level, regional markets, and key developments from market- and technology-oriented perspectives.

Primary Research

Extensive primary research was conducted after obtaining information regarding the vitamin K2 market scenario through secondary research. Several primary interviews were conducted with market experts from the demand and supply sides across all regions. Primary data was collected through questionnaires, emails, and telephonic interviews. The primary sources from the supply side included various industry experts, such as chief experience officers (CXOs), vice presidents (VPs), directors from business development, marketing, research, and development teams, and related key executives from distributors and key opinion leaders.

Primary interviews were conducted to gather insights, including market statistics, revenue data from products and services, market breakdowns, market size estimations, market forecasting, and data triangulation. Primary research also helped to understand the various trends related to product type, function (qualitative), source, application, application form, processing technology (qualitative), and region. Stakeholders from the demand side were interviewed to understand the buyers’ perspective on suppliers, products, and the outlook for their business, which will impact the overall market.

Breakdown of Primary Interviews

Vitamin K2 Market Size, and Share

Note: The three tiers of the companies are defined based on their total revenues in 2024 or 2025, based on the availability of financial data: Tier 1: Revenue >USD 1 billion; Tier 2: USD 100 million ≤ revenue ≤ USD 1 billion; Tier 3: Revenue <USD 100 million.

COMPANY

DESIGNATION

Gnosis by Lesaffre (France)

Regional Sales Manager

Balchem Corp. (US)

Marketing Manager

J-OIL MILLS, INC. (Japan)

General Manager

Novonesis A/S (Denmark)

Sales Manager

Guangdong Sungen Bioscience Co., Ltd. (China)

Sales Manager

Vesta Nutra (US)

Sales Executive

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

The top-down and bottom-up approaches were used to estimate and validate the total size of the vitamin K2 market. These approaches were also used extensively to determine the size of various subsegments in the market. The research methodology used to estimate the market size includes the following details:

  • The key players in the industry and the overall markets were identified through extensive secondary research.
  • All shares, splits, and breakdowns were determined using secondary sources and verified through primary sources.
  • All possible parameters that affect the market covered in this research study were accounted for, viewed in extensive detail, verified through primary research, and analyzed to obtain final quantitative and qualitative data.
  • The research included the study of reports, reviews, and newsletters of top market players, along with extensive interviews for opinions from leaders, such as CEOs, directors, and marketing executives.

Vitamin K2 Market : Top-Down and Bottom-Up Approach

Vitamin K2 Market Top Down and Bottom Up Approach

Data Triangulation

After determining the overall market size from the estimation process explained above, the total market was split into several segments and subsegments. The data triangulation procedure was employed, wherever applicable, to estimate the overall vitamin K2 market and obtain precise statistics for all segments and subsegments. The data was triangulated by studying various factors and trends from the demand and supply sides. The market size was also validated using the top-down and bottom-up approaches.

Market Definition

The vitamin K2 market encompasses a broad category of applications, including dietary supplements, functional foods and beverages, and pharmaceutical products aimed at supporting bone, cardiovascular, and overall health. Vitamin K2 plays a vital role in different health aspects such as calcium metabolism, where it helps in diverting the calcium away from the arteries and soft tissues and guiding them to the teeth and bones, in products targeted at osteoporosis, cardiovascular health, blood clotting, and other functional applications, with different forms available under this broad umbrella, including MK4 and MK7.

Vitamin K2 can be produced from both natural and synthetic sources, with rising focus on the fermentation-sourced ingredients, formulations with high purity, enhanced bioavailability, clean-label solutions, and scientifically validated health benefits. Manufacturing technology is also improving with continued investments in microbial fermentation, strain improvement, purifying technology, microencapsulation, and advanced formulation techniques to improve product stability and shelf life.

The Vitamin K2 market delivers a broad range of uses through dietary supplements, functional foods and beverages, and pharmaceutical formulations to meet the rising demand for preventive healthcare and healthy aging. It forms an important part of the broader nutritional and functional ingredients industry, benefiting from increasing consumer awareness of bone and cardiovascular health, rising adoption of preventive nutrition, growing demand for functional ingredients, and continued investment in scientific research and product innovation.

Key Stakeholders

  • Supply-side: Vitamin K2 manufacturers, fermentation technology providers, synthetic Vitamin K2 producers, raw material providers, ingredient manufacturers, contract manufacturers, private-label producers, formulation specialists, and companies offering purification, encapsulation, and ingredient processing solutions. These stakeholders support the production of Vitamin K2 ingredients for various applications, including dietary supplements, functional foods and beverages, and pharmaceuticals.
  • Technology providers: Companies offering advanced fermenting technology, strain development, bioprocess optimization, purifying and crystallization technologies, microencapsulation systems, testing solutions, quality assurance platforms, process automating technology, and tracing systems. These technologies support product development, ingredient stability, bioavailability, manufacturing efficiency, regulatory compliance, and quality control.
  • Demand side: Dietary supplement manufacturers, pharmaceutical companies, functional food and beverage manufacturers, nutraceutical companies, contract manufacturers, private-label brands, distributors, retailers, pharmacies, and online sales platforms that purchase, formulate, distribute, or commercialize Vitamin K2 ingredients and finished products.
  • Regulatory side: Government agencies and regulatory authorities responsible for ingredient approvals, health regulations, labeling needs, manufacturing standards, food and pharmaceutical safety, quality compliance, and import/export regulations. These organizations oversee ingredient quality, manufacturing practices, product safety, and regulatory compliance across the Vitamin K2 industry.
  • Associations and industry bodies:
    • International Alliance of Dietary/Food Supplement Associations  
    • Council for Responsible Nutrition
    • American Herbal Products Association
    • European Federation of Associations of Health Product Manufacturers
    • Food and Agriculture Organization
    • World Gastroenterology Organization

Report Objectives

  • To determine and project the size of the vitamin K2 market based on product type, function (qualitative), source, application, application form, processing technology (qualitative), and region, over five years, ranging from 2026 to 2031
  • To identify the attractive opportunities in the market by determining the largest and fastest-growing segments across regions
  • To provide detailed information about the key factors influencing market growth (drivers, restraints, opportunities, and challenges)
  • To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
  • To analyze the micro markets with respect to individual growth trends, prospects, and their contribution to the total market
  • To identify and profile the key players in the market
  • To understand the competitive landscape and identify the major growth strategies adopted by players across the key regions

Available customizations:

With the given market data, MarketsandMarkets offers customizations according to company-specific scientific needs. The following customization options are available for the report:

Product Analysis

  • Product matrix gives a detailed comparison of the product portfolio of each company.

Segmental Analysis

  • With the given market data, MarketsandMarkets offers customizations according to company-specific scientific needs.
    • Further breakdown of other functions of Vitamin K2 market by function
    • Further breakdown of other production technologies of Vitamin K2 market into production technology

Company Information

  • Detailed analyses and profiling of additional market players (up to five)

 

Key Questions Addressed by the Report

What is the current size of the global Vitamin K2 market?

The global Vitamin K2 market is estimated to be valued at USD 179.0 million in 2026 and is projected to reach USD 339.9 million by 2031, reflecting strong demand across pharmaceuticals, dietary supplements, and functional foods.

What is the expected CAGR of the Vitamin K2 market?

The Vitamin K2 market is projected to grow at a Compound Annual Growth Rate (CAGR) of 13.7% from 2026 to 2031. Growth is supported by increasing awareness of bone health, cardiovascular wellness, and preventive healthcare.

What factors are driving the growth of the Vitamin K2 market?

The market is driven by rising consumer awareness of Vitamin K2's role in calcium metabolism, increasing demand for dietary supplements, growing aging populations, expanding functional food applications, and scientific research highlighting its cardiovascular and bone health benefits.

What are the latest trends in the Vitamin K2 market?

Key market trends include growing adoption of MK-7 formulations, rising demand for clean-label and naturally sourced ingredients, increased use of Vitamin K2 in functional foods and beverages, and expanding clinical research supporting its health benefits.

What opportunities exist in the Vitamin K2 market?

The Vitamin K2 market offers significant opportunities through innovation in nutraceutical products, expansion into emerging economies, increasing demand for personalized nutrition, and the development of fortified food and beverage products targeting bone and heart health.

Personalize This Research

  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
Request A Free Customisation

Let Us Help You

  • What are the Known and Unknown Adjacencies Impacting the Vitamin K2 Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
Customized Workshop Request

Custom Market Research Services

We Will Customise The Research For You, In Case The Report Listed Above Does Not Meet With Your Requirements

Get 10% Free Customisation

TESTIMONIALS

Growth opportunities and latent adjacency in Vitamin K2 Market

DMCA.com Protection Status
popup img